Popular topics to explore
MedPlus Retail Pharmacy Network Supports Growth
MEDPLUS MedPlus Health Services is a key player in India’s organised pharmacy retail sector, with a growing store network and presence across medicines, wellness products and diagnostics. Rising healthcare awareness, recurring medicine dem…
Why Did MEDPLUS Shares Fall 16%?
MEDPLUS shares declined nearly 16% after the company reported a 21% year-on-year decline in Q1 net profit, disappointing investors despite continued revenue growth.
The decline in profitability was largely attributed to higher operating…
MedPlus Subsidiary Receives Drug License Suspension Order
⚖️ MEDPLUS disclosed that its subsidiary Optival Health Solutions Private Limited has received a 10-day drug license suspension order from the FDA Maharashtra. The order cites alleged violations under the Drugs and Cosmetics Act, 1940, and…
BHEL
STOCKS IN FOCUS TODAY
##Positive Sentiments
• Indian Energy Exchange (IEX) – Power volumes surge across segments
• Atlanta Electricals (!ATLANTAA) – LoA from Punjab State Transmission worth ₹285 Cr
• BHEL – Bags ₹2,000–2,500 Cr orde…
MEDPLUS
It is GOOD because Revenue +24% YoY to ₹1,864 cr; PAT +25% YoY to ₹64 cr; EBITDA margin improved to 5.8% from 5.3%. Full-year FY26 PAT +46% to ₹220 cr. Pharmacy retail is in structural growth phase with organized players growing at 20%+. St…
12th Apr · SEBI-Registered Analyst
Algobazar- Data driven Wealth Management · 12th Apr
Daily Index View : SENSEX as on 12/04/2026
1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 25% 🔍 Key Level to Watch: 76239 🔄 Current Market Surface: The trend will stay Positive until the market stay above 76239 That’s 1311 points away from the last d…
Entero Healthcare & MedPlus – High-Growth Healthcare Gems at a Discount
Two Indian healthcare companies — Entero Healthcare Solutions and Medplus Health Services — have quietly delivered exceptional profit growth, with 5-year CAGRs of 152% and 131% respectively, outpacing most frontline pharma and retail peers.…
MedPlus: Growth at a Reasonable Price?
MEDPLUS MedPlus has emerged as a standout pharmacy‑retail story, delivering triple‑digit profit growth over five years with strong recent‑quarter momentum. The company keeps expanding its store base beyond tier‑I cities, driving higher fo…
9th Feb · SEBI-Registered Analyst
Short Term Investing with M.J Research · 9th Feb
High delivery stocks as on 09/02/2026
Symbol Delivered Qty SCI 10912700 MEDPLUS 626539 KALYANKJIL 8596701 BERGEPAINT 605493 DBREALTY 6344104 IFCI 29708576 KIMS 683513 JYOTHYLAB 755529 GODREJIND 67578 ICICIPRULI 1366129 JUBLPHARMA 204405 SUMICHEM 820153 PATANJALI 3723964 HBLENGI…
Q3FY26 Quarterly Result Announced for Medplus Health Services Ltd. - MEDPLUS
Q3FY26 Quarterly Result Announced for Medplus Health Services Ltd. - MEDPLUS
Healthcare Supplies company Medplus Health Services announced Q3FY26 results
Revenue: Rs 18,061.18 million against Rs 15,614.46 million during Q3FY25, change 16…
MedPlus Subsidiary Faces Drug License Suspensions
⚠️ MEDPLUS informed that its subsidiary, Optival Health Solutions, has received six drug license suspension orders across select stores in Karnataka and Telangana, which may result in a potential revenue impact of approximately ₹6.98 lakh…
MedPlus Subsidiary Receives Drug License Suspension in Maharashtra
💊Optival Health Solutions Private Limited, a subsidiary of MEDPLUS , has received a 10-day drug license suspension for one of its stores in Maharashtra under the Drugs and Cosmetics Act, which may lead to a potential revenue loss of aroun…
MEDPLUS subsidiary, Optival Health Solutions, has received a 10-day drug license suspension order for a store in Ahmednagar, Maharashtra. The order was issued by the Assistant Commissioner Licensing Authority, Food Drug Administrations, Ah…
MedPlus Subsidiary Faces Two-Day Drug License Suspension in Telangana
⚠️ Optival Health Solutions Pvt. Ltd., a subsidiary of MEDPLUS, has received a two-day drug license suspension for one of its Telangana stores under the Drugs and Cosmetics Act. The temporary suspension is expected to result in a potential…
MedPlus currently faces a critical operational and regulatory challenge with the suspension of its licence in one key state/region
MEDPLUS
Signalling serious control and compliance issues that go straight to the heart of its business model of pharmacy retailing and distribution. The company’s core strength — large-scale physical pharmacy presence, high footfall, fas…
MedPlus Subsidiary Faces One-Day Drug License Suspension in Karnataka
Optival Health Solutions Pvt. Ltd., a MEDPLUS subsidiary, has received a one-day drug license suspension for its Alnavara, Karnataka store under the Drugs & Cosmetics Act. The action may lead to a revenue impact of around ₹0.33 lakh, thou…
Optival Health Solutions, a subsidiary of MEDPLUS, has received a three-day suspension order for its drug license at a store in Telangana.
The suspension, issued by the Assistant Director of Drugs Control Administration under the Drugs an…
3rd Nov · SEBI-Registered Analyst
Short Term Investing with M.J Research · 3rd Nov
Stocks having high delivery quantity as on 03/11/25
Symbol Delivered Qty MEDPLUS 1335317 3MINDIA 19123 SCHAEFFLER 230279 SUNDRMFAST 402759 SBFC 5428264 PATANJALI 3219156 APTUS 4123058 MEDANTA 488749 ZENSARTECH 673753 CHOLAHLDNG 314216 CRAFTSMAN 45232 WOCKPHARMA 637701 PHOENIXLTD 1000533 INTE…
📈 MedPlus Health Services Ltd. – Symmetrical Triangle Breakout Setup Emerging
MEDPLUS
MedPlus is showing early breakout signs from a well-defined symmetrical triangle pattern, supported by strong volume and a decisive move above the 30-week SMA. This technical alignment suggests the potential start of a trend conti…
8th Oct · SEBI-Registered Analyst
Short Term Investing with M.J Research · 8th Oct
Stocks having high delivery quantity as on 08/10/25
Symbol Delivered Qty
ITI 4367331
GRAPHITE 1966650
NIVABUPA 5249988
CONCORDBIO 274026
KARURVYSYA 5352755
MEDPLUS 177203
JKTYRE 603658
IFCI 8004533
SFL 124380
HEG 700115
MMTC 2861696
360ONE 1016713
NAVINFLUOR 88134
TATACOMM 284995
ITI
